178 related articles for article (PubMed ID: 26895507)
61. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
62. Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicity.
Oehlke K; Behsnilian D; Mayer-Miebach E; Weidler PG; Greiner R
PLoS One; 2017; 12(2):e0171662. PubMed ID: 28192494
[TBL] [Abstract][Full Text] [Related]
63. Double Redox-Responsive Release of Encoded and Encapsulated Molecules from Patchy Nanocapsules.
Zhao Y; Berger R; Landfester K; Crespy D
Small; 2015 Jul; 11(25):2995-9. PubMed ID: 25712754
[TBL] [Abstract][Full Text] [Related]
64. Development of wrapped liposomes: novel liposomes comprised of polyanion drug and cationic lipid complexes wrapped with neutral lipids.
Yamauchi M; Kusano H; Saito E; Iwata T; Nakakura M; Kato Y; Aoki N
Biochim Biophys Acta; 2006 Jan; 1758(1):90-7. PubMed ID: 16487478
[TBL] [Abstract][Full Text] [Related]
65. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
[TBL] [Abstract][Full Text] [Related]
66. Core functionalization of hollow polymer nanocapsules.
Liu X; Basu A
J Am Chem Soc; 2009 Apr; 131(16):5718-9. PubMed ID: 19351114
[TBL] [Abstract][Full Text] [Related]
67. Mucus penetrating properties of soft, distensible lipid nanocapsules.
Chen H; Mansfield EDH; Woods A; Khutoryanskiy VV; Forbes B; Jones SA
Eur J Pharm Biopharm; 2019 Jun; 139():76-84. PubMed ID: 30818012
[TBL] [Abstract][Full Text] [Related]
68. Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues.
Villegas MR; Baeza A; Vallet-Regí M
ACS Appl Mater Interfaces; 2015 Nov; 7(43):24075-81. PubMed ID: 26461206
[TBL] [Abstract][Full Text] [Related]
69. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
70. Interfacial cationization to quicken redox-responsive drug release.
Zheng Y; Lei J; Li Q; Jin X; Li Q; Li Y
Chem Commun (Camb); 2021 Mar; 57(23):2943-2946. PubMed ID: 33621308
[TBL] [Abstract][Full Text] [Related]
71. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging.
Skandrani N; Barras A; Legrand D; Gharbi T; Boulahdour H; Boukherroub R
Nanoscale; 2014 Jul; 6(13):7379-90. PubMed ID: 24871584
[TBL] [Abstract][Full Text] [Related]
72. Ultrastable Liquid-Liquid Interface as Viable Route for Controlled Deposition of Biodegradable Polymer Nanocapsules.
Vecchione R; Iaccarino G; Bianchini P; Marotta R; D'autilia F; Quagliariello V; Diaspro A; Netti PA
Small; 2016 Jun; 12(22):3005-13. PubMed ID: 27060934
[TBL] [Abstract][Full Text] [Related]
73. Employment of cationic solid-lipid nanoparticles as RNA carriers.
Montana G; Bondì ML; Carrotta R; Picone P; Craparo EF; San Biagio PL; Giammona G; Di Carlo M
Bioconjug Chem; 2007; 18(2):302-8. PubMed ID: 17253655
[TBL] [Abstract][Full Text] [Related]
74. Vesicle-templated layer-by-layer assembly for the production of nanocapsules.
Cuomo F; Lopez F; Miguel MG; Lindman B
Langmuir; 2010 Jul; 26(13):10555-60. PubMed ID: 20235542
[TBL] [Abstract][Full Text] [Related]
75. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
[TBL] [Abstract][Full Text] [Related]
76. Nanoencapsulation of the flavonoid dihydromyricetin protects against the genotoxicity and cytotoxicity induced by cationic nanocapsules.
Dalcin AJF; Vizzotto BS; Bochi GV; Guarda NS; Nascimento K; Sagrillo MR; Moresco RN; Schuch AP; Ourique AF; Gomes P
Colloids Surf B Biointerfaces; 2019 Jan; 173():798-805. PubMed ID: 30551295
[TBL] [Abstract][Full Text] [Related]
77. Design of polymeric nanocapsules to improve their lympho-targeting capacity.
Crecente-Campo J; Virgilio T; Morone D; Calviño-Sampedro C; Fernández-Mariño I; Olivera A; Varela-Calvino R; González SF; Alonso MJ
Nanomedicine (Lond); 2019 Dec; 14(23):3013-3033. PubMed ID: 31696773
[No Abstract] [Full Text] [Related]
78. Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit.
Leonardi A; Bucolo C; Drago F; Salomone S; Pignatello R
Int J Pharm; 2015 Jan; 478(1):180-186. PubMed ID: 25448580
[TBL] [Abstract][Full Text] [Related]
79. The encapsulation of DNA molecules within biomimetic lipid nanocapsules.
Vonarbourg A; Passirani C; Desigaux L; Allard E; Saulnier P; Lambert O; Benoit JP; Pitard B
Biomaterials; 2009 Jun; 30(18):3197-204. PubMed ID: 19329183
[TBL] [Abstract][Full Text] [Related]
80. Cationic additives in nanosystems activate cytotoxicity and inflammatory response of human neutrophils: lipid nanoparticles versus polymeric nanoparticles.
Hwang TL; Aljuffali IA; Lin CF; Chang YT; Fang JY
Int J Nanomedicine; 2015; 10():371-85. PubMed ID: 25609950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
